Plasma fibrinogen level may predict critical coronary artery stenosis in young adults with myocardial infarction

Cardiology Journal

Volumn 16, Issue 4, 2009, Pages 317-320

  Tatli, Ersan ^a   Ozcelik, Faith ^a   Aktoz, Meryem ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Hematological variables; Myocardial infarction; Predictive value of tests; Young patients

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; PROTEIN C; PROTEIN S;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; FAMILY HISTORY; FIBRINOGEN BLOOD LEVEL; HEART CATHETERIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING;

ADULT; ANTITHROMBIN III; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIABETES MELLITUS; FIBRINOGEN; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROTEIN C; PROTEIN S; RISK FACTORS; SMOKING;

EID: 70349492105     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lamm G. The epidemiology of acute myocardial infarction in young age groups. In: Roskamm H ed. Myocardial infarction at young age. Springer-Verlag, Berlin 1981: 5-7.
2. Uhl GS, Farrel PW. Myocardial infarction in young adults: Risk factors and natural history. Am Heart J, 1983; 105: 548-553.
3. Roskamm H, Gohlke H, Sturzenhofecker P. Myocardial infarction at a young age (under 40 years). Int J Sports Med, 1984; 5: 1-10.
4. Fournier JA, Sanchez A, Quero J, Fernandez-Cortacero JA, Gonzalez-Barrero A. Myocardial infarction in men aged 40 years or less: A prospective clinical-angiographic study. Clin Cardiol, 1996; 19: 631-636.
5. Davia JE, Hallal Fj, Cheitlin MD, Gregoratos G, McCarty R, Foote W. Coronary artery disease in young patients: Arteriographic and clinical review of 40 cases aged 35 and under. Am Heart J, 1974; 77: 689-696.
6. Barbash GI, White HD, Modan M et al. Acute myocardial infarction in young - the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J, 1995; 16: 313-316.
7. Williams M, Rentieaux N, Low C. Myocardial infarction in young people with normal coronary arteries. Heart, 1998; 79: 191-194.
8. Braunwald E. Coronary spasm and acute myocardial infarction. New possibility for treatment and prevention. N Eng J Med, 1978; 299: 1301-1302.
9. Hosoi T, Koyama Y, Tange S. Acute myocardial infarction due to vasospasm in a 13 year old boy. Jpn Circ J, 1997; 61: 536-542.
10. Takashiba K, Matsuda Y, Hamada Y et al. Recurrence of myocardial infarction related to diffrent vessels in a patient with diffuse coronary artery spasm without underlying severe organic stenosis. Clin Card, 1988; 11: 265-267.
11. Hoit BD, Gilpin EA, Henning H et al. Myocardial infarction in young patients. An analysis by age subsets. Circulation, 1986; 74: 712-721.
12. Klein LW, Agarwal JB, Herlich MB, Leary TM, Helfant RH. Prognosis of symptomatic coronary artery disease in young adults aged 40 years or less. Am J Cardiol, 1987; 60: 1269-1272.
13. Manzar KJ, Padder FA, Conrad AR, Freeman I, Jonas EA. Acute myocardial infarction with normal coronary artery: A case report and review of literature. Am J Med Sci, 1997; 314: 342-345.
14. Hamsten A, de Faire U, Walldius G. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction. Lancet, 1987; 2: 3-9.
15. Dacosta A, Tardy-P B, Isaaz K. Prevalence factor V Leiden (APCR) and other inherited trombophilias in young patients with myocardial infarction and normal coronary arteries. Heart, 1998; 80: 338-340.
16. Meade TW, North WR, Chakrabarti R. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet, 1980; 1: 1050-1054.
17. Lowe GDO, Drummond MM, Lorimer AR. Relationship between extent of coronary artery disease and blood viscosity. Br Med J, 1980; 1: 673-674.
18. Wllhelmsen K, Svardsudd K, Koraan-Bengaten K, Larsson B, Wolln L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial Infarction. N Engl J Med, 1984; 311: 501-505.
19. Bielak LF, Klee GG, Sheedy PF, Turner ST, Schwartz RS, Peyser PA. Association of fibrinogen with quantity of coronary artery calcification measured by electron beam computed tomography. Arterioscler Thromb Vasc Biol, 2000; 20; 2167-2171.
20. Folsom AR. Fibrinogen and cardiovascular risk markers. Blood Coagul Fibrinolysis, 1999; 10 (suppl. 1): S13-S16.
21. Di Minno G, Cerbone A, Margaglione M, Vecchione G, Grandone E, Mancini M. Fibrinogen and mechanisms of thrombosis. A difficult link. Eur J Epidemiol, 1992; 8 (suppl. 1): S88-S91.
22. ECAT Angina Pectoris Study Group. Baseline association of haemostatic factors with the extent of coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J, 1993; 14: 8-17.
23. Tataru MC, Schulte H, von Eckardstein A, Heinrich J, Assmann G, Koehler E. Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Coron Artery Dis, 2001; 12: 157-165.
24. Engstrom G, Stavenow L, Hedblad B. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke. A population-based study. Diabetes, 2003; 52: 442-447.
25. Gil M, Zarebinski M, Adamus J. Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina. Int J Cardiol, 2002; 83: 43-46.
26. Baller D, Miche A, Prohaska W. Fibrinogen and leucocyte counts as a function of the angiographic and clinical degree of coronary artery disease. In: Ernst E, Koenig W, Lowe GD, Meade TW eds. Fibrinogen: A new cardiovascular risk factor. Blackwell, Wien 1992: 207-213.